Dr Simon Lord

Medical oncology


  • Fee assured

This healthcare professional let us know that they are currently:

  • Accepting new patients
  • Available for:
    • Face-to-face consultations
    • Phone consultations
    • Video consultations

Last updated: 23 Sep 2020

Specialises in

  • Breast

About me

Dr Simon Lord is a Consultant Medical Oncologist at the Oxford Cancer Centre and Clinical Academic at the University of Oxford specialising in the treatment of breast cancer. His main research interest is in the development of new drugs to treat breast cancer and he is a senior member of the Early Phase Clinical Trials Unit at the University of Oxford.

He undertook his oncology training as a Walport Academic Fellow in Leeds and Oxford and in 2010 was awarded a CRUK Clinical Research Fellowship at the Weatherall Institute of Molecular Medicine in Oxford. Here he earned a DPhil for his work investigating therapeutic approaches to target breast cancer metabolism.

He is principal and chief investigator on a number of clinical trials of novel therapies and cancer imaging techniques. He is a module lead for the Precision Cancer Medicine MSc at the University of Oxford and a research fellow at Oriel College, University of Oxford. He sits on the Breast Cancer Now Grants Advisory Committee, National Cancer Research Institute Clinical Trials Pathology Advisory Group Committee and is a board member of the National Cancer Imaging Translational Accelerator (NCITA) Clinical Trials Unit.

Areas of interest

Breast cancer and clinical trials

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.